Baird Maintains Outperform on Biohaven, Raises Price Target to $60
Portfolio Pulse from Benzinga Newsdesk
Baird analyst Brian Skorney maintains an Outperform rating on Biohaven (NYSE:BHVN) and raises the price target from $58 to $60.
September 23, 2024 | 5:20 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Baird analyst Brian Skorney has reaffirmed an Outperform rating for Biohaven and increased the price target from $58 to $60, indicating positive expectations for the stock.
The reaffirmation of an Outperform rating and the increase in price target from $58 to $60 by a reputable analyst suggests a positive outlook for Biohaven's stock. This is likely to boost investor confidence and could lead to a short-term increase in the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100